Almac expanding personalized cancer vaccine production facilities
The Almac Group is doubling its Edinburgh-based footprint to help meet the growing demand for personalized cancer vaccines production.
The Almac Group is doubling its Edinburgh-based footprint to help meet the growing demand for personalized cancer vaccines production.
PinneyAssociates and NMS Labs will plan, conduct, and analyze in vitro laboratory testing of pharmaceutical formulations to evaluate any abuse-deterrent properties, says CMO.
Unchained Labs’ new facility will support its North American customers with specialized services in particle identification and visibility.
August Research is adding clinical trial operations in Georgia and Moldova, expanding the CRO’s reach in Central and Eastern Europe – a less developed market with “fewer competitive trials and lower costs,” says CEO.
LakePharma opens a GMP biorepository facility to assist clients with biomanufacturing and long-term material storage.
Sandoz becomes the latest company to launch a generic version of Mylan’s EpiPen in the US and has undercut its rivals on pricing.
Novo Nordisk Pharmatech selected DKSH to distribute its pharmaceutical grade compounds to the company’s growing customer base in the Asia-Pacific region.
Constantia Flexibles released its new packaging system, the Flexible Blister, which can be incorporated into existing production while offering a portable system for packaging.